60 Degrees Pharmaceuticals(SXTP) - 2024 Q4 - Annual Report

☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2024 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ until ______ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Commission File Number: 001-41719 60 DEGREES PHARMACEUTICALS, INC. Yes ☐ No ☒ Indicate by check mark whether the Registrant (1) has filed all reports required to be file ...